Current Research Studies

FH9880: Multi-center phase II randomized controlled trial of naïve T cell depletion for prevention of chronic graft-versus-host disease in children and young adults

FH9880

Condition(s): Other
Phase: II
Clinicaltrials.gov ID: NCT03779854

What is the goal of the study?

To learn more about this study, please email the study team member listed below.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Marie Bleakley
Study Team Member: Barbara Hilzinger, barbara.hilzinger@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.